Find Research Projects

Search results

• Analysis of intrahepatic macrophage profiles for predicting risk of fibrosis development in patients with different types of chronic liver disease

  Stevenson-Lerner, H.

  National Inst of Diabetes & Digestive &

  4/1/21 → 3/31/26

  Project: Other project

• National Biocontainment Laboratories Operations Support

  Urban, R.

  National Inst of Allergy & Infectious Di

  4/1/21 → 5/31/26

  Project: Other project

• Ryan White Part B

  Keiser, P.

  Resource Group

  4/1/21 → 3/31/22

  Project: Other project

• Health and Aging Policy Fellows Program

  Cram, P.

  4/1/21 → 9/30/21

  Project: Other project

• National Biocontainment Laboratories Operations Support

  Urban, R.

  National Inst of Allergy & Infectious Di

  4/1/21 → 5/31/26

  Project: Other project

• Development of CRISPR-based countermeasures against Ebola virus

  Freiberg, A.

  Sandia National Laboratories

  3/31/21 → 2/28/22

  Project: Other project

• Feasibility Studies: Implementing SMS Messaging to Improve Occupational Health Outcomes Among Commercial Fishers

  Guillot-Wright, S.

  University of Texas Health Ctr at Tyler

  3/31/21 → 9/29/21

  Project: Other project

• Evaluating the Virucidal Efficiency of Xpert Hemorrhagic Fever Test Sample Reagent

  Mire, C.

  Cepheid

  3/31/21 → 12/31/22

  Project: Other project

• Science-based Habit Formation app as an adjunct to the National Diabetes Prevention Program (DPP) Lifestyle Change Program (LCP) to increase engagement, participation, and outcomes of underserved populations and others eligible for the DPP LCP

  Sallam, H.

  Fresh Tri Inc

  3/29/21 → 3/28/23

  Project: Other project

• PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTH

  Rupp, R.

  Pfizer, Inc.

  3/29/21 → 3/28/26

  Project: Other project

• Preclinical Study for the Evaluation of the Xpert GI Panel

  Ren, P.

  Cepheid

  3/29/21 → 3/28/22

  Project: Other project

• Your Diabetes, Your Heart

  Sallam, H.

  Texas A&M Univ Hlth Scis Ctr

  3/29/21 → 9/30/22

  Project: Other project

• UTMB Employee Assistance Fund - Winter Storm URI

  Raimer, B.

  3/26/21 → 3/25/22

  Project: Other project

• Efficacy of AODO2 in the Golden Syrian Hamster -SARS-COV2 Challenge Model

  Brasel, T.

  DSO National Laboratories

  3/19/21 → 3/31/22

  Project: Other project

• Efficacy of AODO2 in the Golden Syrian Hamster -SARS-COV2 Challenge Model

  Brasel, T.

  3/19/21 → 3/31/22

  Project: Other project

• Efficacy of AODO2 in the Golden Syrian Hamster -SARS-COV2 Challenge Model

  Brasel, T.

  3/19/21 → 3/31/22

  Project: Other project

• Efficacy of AODO2 in the Golden Syrian Hamster -SARS-COV2 Challenge Model

  Brasel, T.

  DSO National Laboratories

  3/19/21 → 3/31/22

  Project: Other project

• Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses

  Aguilar, P.

  Fogarty International Center

  3/15/21 → 2/28/26

  Project: Other project

• AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation

  Cisneros, I.

  National Inst on Drug Abuse

  3/15/21 → 2/28/26

  Project: Other project

• Mincle and STING Activation in Proinflammatory Responses to Orientia Infection

  Soong, L.

  National Inst of Allergy & Infectious Di

  3/15/21 → 2/28/23

  Project: Other project

• Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses

  Aguilar, P.

  Fogarty International Center

  3/15/21 → 2/28/26

  Project: Other project

• Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses

  Aguilar, P.

  Fogarty International Center

  3/15/21 → 2/28/26

  Project: Other project

• Molecular Characterization of Transmissible Chromosome Aberrations Produced by Ions of Intermediate and High Atomic Number

  Cornforth, M.

  NASA Johnson Space Center

  3/11/21 → 3/10/24

  Project: Other project

• A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.

  Rupp, R.

  Pfizer, Inc.

  3/11/21 → 3/10/25

  Project: Other project

• Preclinical development of a vaccine for Nipah virus

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/11/21 → 2/28/26

  Project: Other project

• A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.

  Rupp, R.

  3/11/21 → 3/10/25

  Project: Other project

• Preclinical development of a vaccine for Nipah virus

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/11/21 → 2/28/26

  Project: Other project

• Molecular Characterization of Transmissible Chromosome Aberrations Produced by Ions of Intermediate and High Atomic Number

  Cornforth, M.

  NASA Johnson Space Center

  3/11/21 → 3/10/24

  Project: Other project

• SARS-CoV-2 Neutralizing Antibody Titers in African Green Monkey Sera and Nasal Swab Vaccinated with MV-014-212

  Shi, P.

  Meissa Vaccines

  3/10/21 → 8/10/21

  Project: Other project

• Testing 75 negative samples in vitro via microneutralization assay against SARS-CoV-2

  Bukreyev, A.

  Arizona State University

  3/10/21 → 5/10/21

  Project: Other project

• The role of norovirus capsid flexibiity in infection and pathogenesis

  Smith, T.

  3/5/21 → 2/28/23

  Project: Other project

• 1042-SE-3003 A double-blind randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus

  Dabi, A.

  3/4/21 → 3/3/24

  Project: Other project

• Survivor-centered evaluation models for virtual and in-person advocacy: An equity centered approach for Texas

  Wood, L.

  Texas Council on Family Violence

  3/2/21 → 3/31/22

  Project: Other project

• Survivor-centered evaluation models for virtual and in-person advocacy: An equity centered approach for Texas

  Wood, L.

  Texas Council on Family Violence

  3/2/21 → 3/31/22

  Project: Other project

• Dynamics and Health Consequences of Obesity between Infancy and Young Adulthood in the United States

  Mehta, N.

  3/1/21 → 2/28/22

  Project: Other project

• Identifying structural and transcriptional signatures of abnormal chromosomes in single cells

  Nir, G.

  Cancer Prevention and Research Institute

  3/1/21 → 2/28/26

  Project: Other project

• Identifying structural and transcriptional signatures of abnormal chromosomes in single cells

  Nir, G.

  3/1/21 → 2/28/26

  Project: Other project

• Aerus ActivePure Air Purifier Against Respiratory Pathogens

  Lawrence, W.

  ActivePure Medical LLC

  3/1/21 → 11/1/21

  Project: Other project

• Mechanisms of Synaptic Protection in Cognitive Resilience to Alzheimer's Disease Neuropathology

  Limon-Ruiz, A.

  National Inst on Aging

  3/1/21 → 2/28/26

  Project: Other project

• High throughput screening of the Prp8 intein splicing inhibitors for pathogenic fungi

  Zhou, J.

  University of Arizona

  2/26/21 → 11/30/22

  Project: Other project

• Evaluate Therapeutic Efficacies of a Monoclonal Antibody against SARS-CoV-2 Infection in Permissive Human ACE2 Transgenic Mice

  Tseng, C.

  Jecho Laboratories Inc

  2/23/21 → 2/24/22

  Project: Other project

• Evaluate Therapeutic Efficacies of a Monoclonal Antibody against SARS-CoV-2 Infection in Permissive Human ACE2 Transgenic Mice

  Tseng, C.

  Jecho Laboratories Inc

  2/23/21 → 2/24/22

  Project: Other project

• A multicenter, randomized, double-blind, double-dummy, parallel group, active controlled study to evaluate the effect of sacubitril/valsartan (LCZ696) versus valsartan on changes in NT-proBNP and outcomes, safety, and tolerability in HFpEF patients with

  Khalife, W.

  Novartis Pharmaceuticals Corporation

  2/15/21 → 12/31/21

  Project: Other project

• (Pfizer Pregnant COVID Vaccine C4591015) A PHASE 2/3, PLACEBO CONTROLLED, RANDOMIZED, OBSERVER BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS COV 2 RNA VACCINE CANDIDATE (BNT162b2) AGAINST COVID 19 IN HEALTHY PREGNANT WOME

  Saade, G.

  Pfizer, Inc.

  2/10/21 → 2/9/26

  Project: Other project

• Epigenetic Mechanisms Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma

  Yang, J.

  University of Wisconsin-Madison

  2/1/21 → 1/31/22

  Project: Other project

• Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models (resubmission of AI53524)

  Chopra, A.

  National Inst of Allergy & Infectious Di

  2/1/21 → 7/31/25

  Project: Other project

• Infectious Diseases and Inflammatory Disorders Training Program

  Wang, T.

  National Inst of Allergy & Infectious Di

  2/1/21 → 1/31/26

  Project: Other project

• High throughput screening of orthosteric inhibitors of flavivirus protease

  Zhou, J.

  University of Arizona

  2/1/21 → 1/31/23

  Project: Other project

• T cell-Alveolar Macrophage Crosstalk during influenza and Streptococcus Pneuomoniae Co-infection

  Sun, K.

  2/1/21 → 7/31/21

  Project: Other project

• STATE OF TEXAS CHILD MENTAL HEALTH CARE CONSORTIUM (TCMHCC) CORE 1 CPAN, CORE 2 TCHATT, CORE 3 CPWE CORE 4 CAP FELLOWSHIP - AS REQUIRED BY RIDER 58 OF THE APPROPRIATION TO THE TEXAS HIGHER EDUCATION COORDINATING BOARD - (HOUSE BILL 1, 86TH LEGISLATUR

  Wagner, K.

  2/1/21 → 8/31/21

  Project: Other project